These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15638076)

  • 1. [Inhibition of the arachidonic acid cascade by aza-2-aryl-1,4-naphthoquinone derivatives].
    Richwien A; Wurm G
    Pharmazie; 2004 Dec; 59(12):906-12. PubMed ID: 15638076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of 2-aryl-3-halogen/3-hydroxy-1,4-naphthoquinones with salicylic and cinnamic acid partial structures on the arachidonic acid cascade].
    Richwien A; Wurm G
    Pharmazie; 2004 Mar; 59(3):163-9. PubMed ID: 15074584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
    Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [2-(3-Halogen-4-hydroxyphenyl)-1,4-napthoquinone derivatives from 2-(3,5-di-tert-butyl-4-hydroxyphenyl)-analogs, potent 5-lipoxygenase inhibitors. 27. 1,4-Naphthoquinones].
    Wurm G; Schwandt S
    Pharmazie; 1999 Jul; 54(7):487-90. PubMed ID: 10445242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of maesanin and analogs on arachidonic acid metabolizing enzymes.
    Abourashed EA; Muhammad I; Resch M; Bauer R; el-Feraly FS; Hufford CD
    Planta Med; 2001 Jun; 67(4):360-1. PubMed ID: 11458456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade.
    Tavolari S; Bonafè M; Marini M; Ferreri C; Bartolini G; Brighenti E; Manara S; Tomasi V; Laufer S; Guarnieri T
    Carcinogenesis; 2008 Feb; 29(2):371-80. PubMed ID: 18033773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of acyclic triaryl (Z)-olefins possessing a 3,5-di-tert-butyl-4-hydroxyphenyl pharmacophore: dual inhibitors of cyclooxygenases and lipoxygenases.
    Moreau A; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Aug; 14(15):5340-50. PubMed ID: 16677817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
    Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
    J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Partially hydrogenated aryl-1,2/1,4-anthraquinone derivatives, 5-lipoxygenase inhibitors with arotinoid structure].
    Wurm G; Probst R; Schwandt S
    Pharmazie; 2001 Jul; 56(7):527-33. PubMed ID: 11487969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methylated 2-aryl-1,4-naphtoquinone derivatives with diminished antioxidative activity].
    Wurm G; Schwandt S
    Pharmazie; 2003 Aug; 58(8):531-8. PubMed ID: 12967027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
    Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
    Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency.
    Boehm JC; Smietana JM; Sorenson ME; Garigipati RS; Gallagher TF; Sheldrake PL; Bradbeer J; Badger AM; Laydon JT; Lee JC; Hillegass LM; Griswold DE; Breton JJ; Chabot-Fletcher MC; Adams JL
    J Med Chem; 1996 Sep; 39(20):3929-37. PubMed ID: 8831759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of conformationally constrained aci-reductone mimics of arachidonic acid.
    Hopper AT; Witiak DT; Ziemniak J
    J Med Chem; 1998 Feb; 41(4):420-7. PubMed ID: 9484493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme selectivity of new cyclooxygenase-2/5 lipoxygenase inhibitors using molecular modeling approach.
    Kothekar V; Sahi S; Mishra J
    Indian J Biochem Biophys; 2000 Apr; 37(2):86-96. PubMed ID: 10983419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of N-difluoromethyl-1,2-dihydropyrid-2-one acetic acid regioisomers: dual inhibitors of cyclooxygenases and 5-lipoxygenase.
    Yu G; Praveen Rao PN; Chowdhury MA; Abdellatif KR; Dong Y; Das D; Velázquez CA; Suresh MR; Knaus EE
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2168-73. PubMed ID: 20202839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of inhibitors of arachidonic acid metabolism on corneal reepithelialization in the rat.
    Gupta AG; Hirakata A; Proia AD
    Exp Eye Res; 1993 Jun; 56(6):701-8. PubMed ID: 8595812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase.
    Albert D; Zündorf I; Dingermann T; Müller WE; Steinhilber D; Werz O
    Biochem Pharmacol; 2002 Dec; 64(12):1767-75. PubMed ID: 12445866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of natural products containing acylresorcinol partial structures on cyclooxygenases and 5-lipoxygenase.
    Bracher F; Krauss J; Laufer S
    Pharmazie; 2001 May; 56(5):430. PubMed ID: 11400568
    [No Abstract]   [Full Text] [Related]  

  • 19. Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity.
    Hamer RR; Tegeler JJ; Kurtz ES; Allen RC; Bailey SC; Elliott ME; Hellyer L; Helsley GC; Przekop P; Freed BS; White J; Martin LL
    J Med Chem; 1996 Jan; 39(1):246-52. PubMed ID: 8568814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual inhibition of cyclooxygenase and lipoxygenase by human haptoglobin: its polymorphism and relation to hemoglobin binding.
    Saeed SA; Ahmad N; Ahmed S
    Biochem Biophys Res Commun; 2007 Feb; 353(4):915-20. PubMed ID: 17198677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.